SCHEMBL9327700

SCHEMBL9327700

O=C1c2cccc3cccc(c23)C(=O)N1CBr

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 2/20 0.67
▸ HEXA P06865 6/20 0.62
▸ HEXB P07686 6/20 0.62
▸ ALDH1A1 P00352 4/20 0.61
▸ KDM4E B2RXH2 3/20 0.61
▸ MAPT P10636 2/20 0.61
▸ HPGD P15428 2/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ AKR1B1 P15121 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ OGA O60502 1/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ GAA P10253 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ ERCC1 P07992 1/20 0.57
▸ FEN1 P39748 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10396736 0.85 HEXA (0.69) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL10262751 0.83 CYP1B1 (0.71) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL19422173 0.83 CYP1B1 (0.47) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL8879380 0.82 HEXA (0.71) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL30116495 0.81 CA12 (0.54) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL113005 0.81 CA12 (0.54) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL8879310 0.80 HEXA (0.71) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL13207607 0.80 HEXA (0.73) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL10795642 0.80 CYP1B1 (0.67) CYP1B1HEXAHEXBALDH1A1KDM4E
SCHEMBL9626265 0.80 HEXA (0.83) CYP1B1HEXAHEXBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304549-A Control or prevention of degenerative joint diseases HOFFMANN-LA ROCHE INC. (US) 1994-04-19 — — US disclosed
EP-0497192-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1992-08-05 — — EP disclosed
Send feedback